COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"COVID‐19 and Its Cardiovascular Effects: a Systematic Review of Prevalence Studies." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436859/all/Amplification_with_hearing_aids_for_patients_with_tinnitus_and_co‐existing_hearing_loss_New. Accessed 23 April 2024.
COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436859/all/Amplification_with_hearing_aids_for_patients_with_tinnitus_and_co‐existing_hearing_loss_New. Accessed April 23, 2024.
COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436859/all/Amplification_with_hearing_aids_for_patients_with_tinnitus_and_co‐existing_hearing_loss_New
COVID‐19 and Its Cardiovascular Effects: a Systematic Review of Prevalence Studies [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436859/all/Amplification_with_hearing_aids_for_patients_with_tinnitus_and_co‐existing_hearing_loss_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies
ID - 436859
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436859/all/Amplification_with_hearing_aids_for_patients_with_tinnitus_and_co‐existing_hearing_loss_New
DB - Evidence Central
DP - Unbound Medicine
ER -